Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 2,143 | 352 | 197 | 422 | 109 |
| Operating Income | -2,143 | -352 | -197 | -422 | -109 |
| Interest Expense | 68 | 104 | 68 | 67 | 70 |
| Other Income | 53 | 0 | 0 | 2 | 5 |
| Pre-tax Income | -2,158 | -456 | -265 | -488 | -175 |
| Net Income Continuous | -2,158 | -456 | -265 | -488 | -175 |
| Net Income | $-2,158 | $-456 | $-265 | $-488 | $-175 |
| EPS Basic Total Ops | -0.04 | -0.01 | 0.00 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.04 | -0.01 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.04 | -0.01 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.04 | -0.01 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-2,090 | $-352 | $-197 | $-421 | $-104 |